Nob Hill Therapeutics is established to commercialize the first dry-powder nebulizer to treat severe respiratory diseases.
Nob Hill Therapeutics has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Nob Hill Therapeutics's investors include VIC Technology Venture Development, TCA Venture Group, New Mexico Economic Development Department, New Mexico Angels, Tramway Venture Partners.
Nob Hill Therapeutics is headquartered in Albuquerque, United States.
Nob Hill Therapeutics is established to commercialize the first dry-powder nebulizer to treat severe respiratory diseases.
Nob Hill Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nob Hill Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/nob-hill-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Nob Hill Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nob-hill-therapeutics
{{cite web |title=Nob Hill Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nob-hill-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated